39-year old David Einhorn runs a hedge fund with assets under management of $5 billion, but he isn't content with that. Today's Wall Street Journal reports (subscription required) on his new book, Fooling Some of the People All of the Time: A Long Short Story, detailing his public crusade against Allied Capital (NYSE: ALD), which he has accused of fraudulent accounting. Mr. Einhorn is short the stock.
In the book, he also lashes out at the SEC, which has been the target of criticism from fraudsters, fraud-busters, and the anti naked short selling baloney brigade.
Einhorn told the Journal that "The SEC is run by a corporate advocate, not an investor advocate, so investors are getting a false sense of security."
That's a pretty serious criticism, but it seems to be supported by some of the commission's recent actions, including its decision to make it even tougher for investors to hold underperforming directors accountable.
I ordered a copy of the book a few days ago and will post a review as soon as possible.
Last updated: February 12, 2012: 05:24 PM
Hot Stocks
DailyFinance Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
Benzinga Headlines
- Michigan Consumer Sentiment Index Drops
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
- Chesapeake Gently Lets Go of Gas
- How to Profit off Addicts
TheFlyOnTheWall.com Headlines
- Xstrata shareholders want Glencore offer above three shares, Telegraph says
- France Telecom pursuing greater interest in Egypt's Mobinil, Bloomberg says
- Arab league to ask U.N. for a peacekeeping force in Syria, WSJ says
- Apple asks for preliminary injunction of Samsung Galaxy Nexus, AppleInsider says
- Some walnut growers want to stop selling to Diamond, Reuters says
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Tax Reform in This Election Year: It's Not Likely
Walmart's New Health Food Push: Is It Too Hard to Swallow?


Reader Comments (Page 1 of 1)
4-28-2008 @ 3:53PM
B. Harrison said...
Well, hasn't that been a criticism of the SEC for quite some time. The American stockholders need to pressure their Congressmen to get these matters resolved.
We're being taken to the cleaners on a daily basis by unscroupulous corporate managment and Congress doesn't do a darnthing about it; they have oversight and control over the SEC.
5-03-2008 @ 7:01PM
Al Swearengen said...
I'm 3/4 of the way through his book, and I've now begun researching various names from within...especially a certain professor from Harvard Business School.
Anyone who is serious about investing should read this book!